Filtros de búsqueda

Lista de obras de

-OMICS AND PROGNOSTIC MARKERS

artículo científico publicado en 2011

A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomas

artículo científico publicado en 2008

A PHASE I STUDY OF CONVECTION-ENHANCED DELIVERY OF LIPOSOMAL-IRINOTECAN USING REAL-TIME IMAGING WITH GADOLINIUM IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA.

artículo científico publicado en 2014

A hierarchy of self-renewing tumor-initiating cell types in glioblastoma

artículo científico publicado en 2010

A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study.

artículo científico publicado en 2006

A phase I trial of temozolomide and lomustine in newly diagnosed high-grade gliomas of childhood

artículo científico publicado en 2008

A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study.

artículo científico publicado en 2017

A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931).

artículo científico publicado en 2009

A pilot precision medicine trial for children with diffuse intrinsic pontine glioma-PNOC003: A report from the Pacific Pediatric Neuro-Oncology Consortium

artículo científico publicado en 2019

A prognostic gene expression signature in infratentorial ependymoma

artículo científico publicado en 2012

A “PRECISION MEDICINE” STRATEGY FOR RECURRENT GLIOBLASTOMA.

artículo científico publicado en 2014

AT-25A PHASE I STUDY OF CONVECTION-ENHANCED DELIVERY OF LIPOSOMAL-IRINOTECAN USING REAL-TIME IMAGING WITH GADOLINIUM IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA.

artículo científico publicado en 2014

ATCT-32A PHASE II STUDY OF TEMOZOLOMIDE IN THE TREATMENT OF ADULT PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMA.

artículo científico publicado en 2015

ATNT-17 EVALUATION OF THE SAFETY AND BENEFIT OF PHASE I ONCOLOGY TRIALS FOR PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM TUMORS

artículo científico publicado en 2015

Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors.

artículo científico publicado en 2002

Abstract 3667: The Pediatric Brain Tumor Atlas - Transforming the landscape of research

scholarly article

Acquired resistance to BRAF inhibition in BRAFV600E mutant gliomas

artículo científico publicado en 2017

Activation of PI3K/mTOR pathway occurs in most adult low-grade gliomas and predicts patient survival

artículo científico publicado en 2009

An experimental xenograft mouse model of diffuse pontine glioma designed for therapeutic testing

artículo científico publicado en 2012

Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survival.

artículo científico publicado en 2003

Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study

artículo científico publicado en 2012

Association of Diffusion and Anatomic Imaging Parameters with Survival for Patients with Newly Diagnosed Glioblastoma Participating in Two Different Clinical Trials

artículo científico publicado en 2015

Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma

scientific article published on 06 February 2020

Benefit of temozolomide compared to procarbazine in treatment of glioblastoma multiforme at first relapse: effect on neurological functioning, performance status, and health related quality of life

artículo científico publicado en 2005

Biopsy for diffuse intrinsic pontine glioma: a reappraisal

artículo científico publicado en 2016

Brain metastases of breast cancer

artículo científico publicado en 2005

Brain tumors: from childhood through adolescence into adulthood

scientific article published on 10 May 2010

Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial

scientific article published on 04 February 2019

Central nervous system cancers

artículo científico publicado en 2008

Central nervous system cancers: Clinical Practice Guidelines in Oncology.

artículo científico publicado en 2005

Characterization of a diffuse intrinsic pontine glioma cell line: implications for future investigations and treatment

artículo científico publicado en 2012

Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide

artículo científico publicado en 2016

Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery

artículo científico publicado en 2011

Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients

artículo científico publicado en 2014

Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience

artículo científico publicado en 2015

Clinical trial endpoints for patients with gliomas

scientific article published on 14 February 2017

Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy

artículo científico publicado en 2018

Combined BRAFV600E and MEK blockade for BRAFV600E-mutant gliomas.

artículo científico publicado en 2016

Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab

artículo científico publicado en 2014

Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

artículo científico

Comprehensive Characterization of Cancer Driver Genes and Mutations

article

Conditional probability of survival in patients with newly diagnosed glioblastoma

artículo científico publicado en 2011

Corticosteroid Use in Patients with Glioblastoma at First or Second Relapse Treated with Bevacizumab in the BRAIN Study ⬇️

artículo científico publicado el 8 de diciembre de 2010

Cytokines associated with toxicity in the treatment of recurrent glioblastoma with aflibercept

artículo científico publicado en 2013

DIPG-15. PNOC-003: CLINICAL IMPACT OF A PRECISION MEDICINE STRATEGY FOR CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA ⬇️

DIPG-32. CLINICALLY RELEVANT AND MINIMALLY INVASIVE TUMOR SURVEILLANCE IN PEDIATRIC GLIOMAS USING LIQUID BIOME

DIPG-34. PRECLINICAL PRECISION TESTING OF PNOC003 BIOPSY DERIVED MODELS OF DIPG

artículo científico publicado en 2019

DIPG-39. LIQUID BIOPSY FOR MONITORING OF TUMOR RESPONSE IN CHILDREN WITH MIDLINE GLIOMAS.

artículo científico publicado en 2017

DIPG-40. PNOC-003: PRECISION MEDICINE TRIAL FOR CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA.

artículo científico publicado en 2017

DIPG-76. PNOC-003: PRECISION MEDICINE TRIAL FOR CHILDREN WITH DIFFUSES INTRINSIC PONTINE GLIOMA: PRELIMINARY EXPERIENCE WITH MULTI-AGENT PERSONALIZED THERAPY RECOMMENDATIONS

DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression.

artículo científico publicado en 2011

Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging

artículo científico publicado en 2005

ED-36INHERITED VARIANTS NEAR TERC AND TERT ARE ASSOCIATED WITH LONGER TELOMERES AND INCREASED GLIOMA RISK: GENOME-WIDE ASSOCIATION RESULTS FROM THE UCSF ADULT GLIOMA STUDY AND THE ENGAGE CONSORTIUM TELOMERE GROUP.

artículo científico publicado en 2014

EGFR blockade prevents glioma escape from BRAFV600E targeted therapy

artículo científico publicado en 2015

Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: a phase I study

artículo científico publicado en 2010

Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma

artículo científico publicado en 2007

Erratum to: Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma.

artículo científico publicado en 2016

Evaluation of the Safety and Benefit of Phase I Oncology Trials for Patients With Primary CNS Tumors.

artículo científico publicado en 2015

Feasibility, safety, and indications for surgical biopsy of intrinsic brainstem tumors in children.

artículo científico publicado en 2013

GENE-15. CAVATICA- A PEDIATRIC GENOMIC CLOUD EMPOWERING DATA DISCOVERY THROUGH THE PEDIATRIC BRAIN TUMOR ATLAS.

artículo científico publicado en 2017

GENE-18. PAN-OMIC ANALYSIS OF DIFFUSE INTRINSIC PONTINE GLIOMA FROM CHILDREN ENROLLED IN THE PNOC003 PRECISION MEDICINE TRIAL IDENTIFIES OPPORTUNITIES AND CHALLENGES IN CLINICAL IMPLEMENTATION OF A MULTI-OMICS SEQUENCING APPROACH

artículo científico publicado en 2019

GENE-20. MULTI-GENE MUTATION PROFILING OF PEDIATRIC MIDLINE GLIOMAS USING PATIENT LIQUID BIOPSY

artículo científico publicado en 2019

GENE-43. LIQUID BIOPSY FOR MONITORING OF TUMOR RESPONSE IN CHILDREN WITH DIFFUSE MIDLINE GLIOMA

GENO-21BRCA1 PROTEIN EXPRESSION PREDICTS SURVIVAL IN GLIOBLASTOMA PATIENTS FROM A NRG ONCOLOGY/RTOG COHORT.

artículo científico publicado en 2015

GENO-29MUTATIONAL DIVERSITY UNDERLYING TELOMERE MAINTENANCE MECHANISMS IN AN APPRECIABLE FRACTION OF ADULT GLIOMAS.

artículo científico publicado en 2015

Gene expression and angiotropism in primary CNS lymphoma

artículo científico

Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma.

artículo científico publicado en 2002

Gliomatosis cerebri: a review of 22 cases

artículo científico publicado en 2003

HG-115PRECISION MEDICINE APPROACH FOR CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA.

artículo científico publicado en 2016

HG-73SAFETY AND FEASIBILITY OF A MULTI-INSTITUTIONAL PHASE II TRIAL INCOPORATING BIOPSY AND MOLECULARLY DETERMINED TREATMENT OF CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPG).

artículo científico publicado en 2016

HGG-38. DEVELOPMENT AND COMPREHENSIVE CHARACTERIZATION AND UTILIZATION OF PRECLINICAL MODELS OF PEDIATRIC HIGH GRADE GLIOMAS

High failure rate in spinal ependymomas with long-term follow-up

artículo científico publicado en 2005

High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system

artículo científico publicado en 2009

Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system

artículo científico publicado en 2013

Historical controls for phase II surgically based trials requiring gross total resection of glioblastoma multiforme

artículo científico publicado en 2007

Identifying the needs of brain tumor patients and their caregivers

artículo científico publicado en 2011

IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era.

artículo científico publicado en 2009

Inherited variation in immune genes and pathways and glioblastoma risk

artículo científico publicado en 2010

Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma

artículo científico publicado en 2009

It is time to include patients with brain tumors in phase I trials in oncology

artículo científico publicado en 2011

MB-52RESPONSE ASSESSMENT IN PEDIATRIC NEURO-ONCOLOGY (RAPNO) COMMITTEE GUIDELINES FOR RESPONSE ASSESSMENT IN MEDULLOBLASTOMA AND OTHER LEPTOMENINGEAL SEEDING TUMORS.

artículo científico publicado en 2016

MUTATION-BASED MOLECULAR GLIOMA CLASSIFICATION: PREVALENCE AND ASSOCIATION WITH GERMLINE RISK SNPS.

artículo científico publicado en 2014

Management of a sporadic malignant subfrontal peripheral nerve sheath tumor

artículo científico publicado en 2006

Mechanisms of Resistance to EGFR Inhibition Reveal Metabolic Vulnerabilities in Human GBM

scientific article published on 03 July 2019

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

artículo científico publicado en 2005

Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01.

artículo científico publicado en 2005

Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma

artículo científico publicado en 2012

Multiscale, multimodal analysis of tumor heterogeneity in IDH1 mutant vs wild-type diffuse gliomas

artículo científico publicado en 2019

Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with aflibercept

artículo científico publicado en 2011

NI-61VOLUMETRIC H-1 MR METABOLIC IMAGING FOR DEFINITION OF LESION BURDEN AND PREDICTION OF OUTCOME FOR PATIENTS WITH NEWLY DIAGNOSED GBM.

artículo científico publicado en 2014

NIMG-53. POST-SURGICAL, RESIDUAL ENHANCING TUMOR VOLUME IS PROGNOSTIC FOR OVERALL SURVIVAL IN NEWLY DIAGNOSED GLIOBLASTOMA: EVIDENCE FROM 1,458 PATIENTS POOLED FROM INTERNATIONAL TRIALS, SINGLE INSTITUTION DATABASES, AND MULTICENTER CONSORTIUMS

NIMG-84. TUMOR LOCATION IS PROGNOSTIC FOR OVERALL SURVIVAL IN NEWLY DIAGNOSED GLIOBLASTOMA: EVIDENCE FROM 1,458 PATIENTS POOLED FROM INTERNATIONAL TRIALS, SINGLE INSTITUTION DATABASES, AND MULTICENTER CONSORTIUMS

Neuro-Oncology Practice Clinical Debate: targeted therapy vs conventional chemotherapy in pediatric low-grade glioma

scientific article published on 13 August 2019

Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab

artículo científico publicado en 2011

Neuroradiographic changes following convection-enhanced delivery of the recombinant cytotoxin interleukin 13-PE38QQR for recurrent malignant glioma

artículo científico publicado en 2005

Nonsynonymous coding single-nucleotide polymorphisms spanning the genome in relation to glioblastoma survival and age at diagnosis

artículo científico publicado en 2007

O6-benzylguanine suppression of O6-alkylguanine-DNA alkyltransferase in anaplastic gliomas

artículo científico publicado en 2004

OP02ADOLESCENT/YOUNG ADULT MEDULLOBLASTOMA: TIME FOR A CHANGE IN MANAGEMENT STRATEGY.

artículo científico publicado en 2015

Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study

artículo científico publicado en 2015

PATH-08. THE IVY GLIOBLASTOMA PATIENT ATLAS - A NOVEL CLINICAL AND RADIO-GENOMICS RESOURCE FOR EARLY PHASE CLINICAL TRIAL DESIGN AND INTERPRETATION

artículo científico publicado en 2018

PDCT-19. A SAFETY STUDY OF VEMURAFENIB, AN ORAL INHIBITOR OF BRAF, IN CHILDREN WITH RECURRENT/REFRACTORY BRAF MUTANT BRAIN TUMORS: PNOC-002

PDCT-20. FEASIBILITY AND SAFETY OF SURGICAL BIOPSY FOR PATIENTS WITH DIPG: PRELIMINARY RESULTS FROM DIPG-BATS

artículo científico publicado en 2017

PHASE II TRIAL OF THE PHOSPHATIDYINOSITOL-3 KINASE (PI3K) INHIBITOR BUPARLISIB (BKM120) IN RECURRENT GLIOBLASTOMA CONDUCTED BY THE IVY FOUNDATION EARLY PHASE CLINICAL TRIALS CONSORTIUM.

artículo científico publicado en 2014

PL-03FEASIBILITY OF GENOMICS-ENABLED THERAPY FOR PEDIATRIC HIGH-GRADE GLIOMAS AND DIFFUSE PONTINE GLIOMAS.

artículo científico publicado en 2014

PTEN promoter methylation and activation of the PI3K/Akt/mTOR pathway in pediatric gliomas and influence on clinical outcome

artículo científico publicado en 2012

Pharmacokinetic and tumor distribution characteristics of temsirolimus in patients with recurrent malignant glioma.

artículo científico publicado en 2007

Pharmacologic inhibition of cyclin-dependent kinases 4 and 6 arrests the growth of glioblastoma multiforme intracranial xenografts

artículo científico publicado en 2010

Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study

artículo científico publicado en 2004

Phase I clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors: a pediatric brain tumor consortium study (PBTC-001).

artículo científico publicado en 2005

Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma

artículo científico publicado en 2007

Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02.

artículo científico publicado en 2017

Phase I study of temozolomide and irinotecan for recurrent malignant gliomas in patients receiving enzyme-inducing antiepileptic drugs: a north american brain tumor consortium study

artículo científico publicado en 2007

Phase I study of vemurafenib in children with recurrent or progressive BRAFV600E mutant brain tumors: Pacific Pediatric Neuro-Oncology Consortium study (PNOC-002)

scientific article published on 26 May 2020

Phase I study of vorinostat in combination with temozolomide in patients with high-grade gliomas: North American Brain Tumor Consortium Study 04-03.

artículo científico publicado en 2012

Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas

artículo científico publicado en 2017

Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma

artículo científico publicado en 2008

Phase I trial of tipifarnib in patients with recurrent malignant glioma taking enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study.

artículo científico publicado en 2005

Phase I/II Trial of Vorinostat Combined with Temozolomide and Radiation Therapy for Newly Diagnosed Glioblastoma: Final Results of Alliance N0874/ABTC 02.

artículo científico publicado en 2017

Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02

artículo científico publicado en 2014

Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02.

artículo científico publicado en 2012

Phase II TPDCV protocol for pediatric low-grade hypothalamic/chiasmatic gliomas: 15-year update ⬇️

artículo científico publicado en 2010

Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American Brain Tumor Consortium study

artículo científico publicado en 2003

Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients naive to antiangiogenic therapy

artículo científico publicado en 2017

Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients with prior antiangiogenic therapy

artículo científico publicado en 2017

Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma

artículo científico publicado en 2008

Phase II study of fenretinide (NSC 374551) in adults with recurrent malignant gliomas: A North American Brain Tumor Consortium study

artículo científico publicado en 2004

Phase II study of high central dose Gamma Knife radiosurgery and marimastat in patients with recurrent malignant glioma

artículo científico publicado en 2002

Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial

artículo científico publicado en 2004

Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02).

artículo científico publicado en 2010

Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas

artículo científico publicado en 2011

Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas

artículo científico publicado en 2003

Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.

artículo científico publicado en 2004

Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma

artículo científico publicado en 2010

Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma

scientific article published on 27 August 2018

Population Pharmacokinetics of Vemurafenib in Children With Recurrent/Refractory BRAF Gene V600E-Mutant Astrocytomas

artículo científico publicado en 2020

Precision knockdown of EGFR gene expression using radio frequency electromagnetic energy.

artículo científico publicado en 2017

Probing the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low-grade gliomas.

artículo científico publicado en 2017

Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma.

artículo científico publicado en 2006

Prospective Feasibility and Safety Assessment of Surgical Biopsy for Patients with Newly Diagnosed Diffuse Intrinsic Pontine Glioma.

artículo científico publicado en 2018

QOLP-24. ATTITUDES TOWARD FERTILITY AND FERTILITY PRESERVATION IN WOMEN WITH GLIOMA

article by Rachel Stiner et al published 5 November 2018 in Neuro-Oncology

Quality of Life and Patterns of Use of Complementary and Alternative Medicines Among Glioma Patients

artículo científico publicado en 2009

Quality of life in low-grade glioma patients receiving temozolomide

artículo científico publicado en 2008

RARE-13. Clinical management and functional and survival outcomes in pediatric craniopharyngioma, a patient and family perspective

scientific article published in 2022

RARE-17. Multi-institutional craniopharyngioma cohort highlights need for more comprehensive data collection on comorbidities and quality of life

artículo científico publicado en 2022

Radiation therapy for intracranial germ cell tumors

artículo científico publicado en 2003

Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children's Oncology Group

artículo científico publicado en 2012

Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma

artículo científico publicado en 2014

Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab ⬇️

artículo científico publicado el 17 de noviembre de 2010

SG-01FEEDBACK ACTIVATION OF EGFR VIA PTPN9 LEADS TO GLIOMA ESCAPE FROM BRAFV600E TARGETED THERAPY.

artículo científico publicado en 2015

SSBP2 variants are associated with survival in glioblastoma patients

scientific journal article

SURG-02. A NOVEL RISK MODEL TO DEFINE THE RELATIVE BENEFIT OF MAXIMAL EXTENT OF RESECTION WITHIN PROGNOSTIC GROUPS IN NEWLY DIAGNOSED GLIOBLASTOMA

Safety and efficacy of erlotinib in first-relapse glioblastoma: a phase II open-label study

artículo científico publicado en 2010

Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma

artículo científico publicado en 2003

Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab

artículo científico publicado en 2016

Six-month progression-free survival as an alternative primary efficacy endpoint to overall survival in newly diagnosed glioblastoma patients receiving temozolomide

artículo científico publicado en 2009

Subependymal spread of recurrent glioblastoma detected with the intraoperative use of 5-aminolevulinic acid: case report.

artículo científico publicado en 2013

Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma

artículo científico publicado en 2015

TARGETING GLIOMA INITIATING CELLS IN GBM: ABTC-0904, A RANDOMIZED PHASE 0/II STUDY TARGETING THE SONIC HEDGEHOG-SIGNALING PATHWAY.

artículo científico publicado en 2014

THER-26. PHARMACOKINETIC AND UPDATED OUTCOME DATA FROM PNOC-002: A SAFETY STUDY OF VEMURAFENIB, AN ORAL INHIBITOR OF BRAFV600E, IN CHILDREN WITH RECURRENT/REFRACTORY BRAFV600E MUTANT BRAIN TUMORS

TMOD-20. THE PEDIATRIC BRAIN TUMOR ATLAS: AN INITIATIVE BY THE CHILDREN’S BRAIN TUMOR TISSUE CONSORTIUM AND PACIFIC PEDIATRIC NEUROONCOLOGY CONSORTIUM

TRTH-23. FEASIBILITY AND SAFETY OF SURGICAL BIOPSY FOR PATIENTS WITH DIPG: PRELIMINARY RESULTS FROM DIPG-BATS.

artículo científico publicado en 2017

Temozolomide in the treatment of recurrent malignant glioma

artículo científico publicado en 2004

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

article

The Somatic Genomic Landscape of Glioblastoma

article

The role of up-front radiation therapy for incompletely resected pediatric WHO grade II low-grade gliomas

artículo científico publicado en 2006

The somatic genomic landscape of glioblastoma

artículo científico publicado en 2013

Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis

artículo científico publicado en 2016

Validation of post-operative residual contrast enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma.

artículo científico publicado en 2018

Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility

artículo científico publicado en 2009

Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk

artículo científico publicado en 2014

Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032.

artículo científico publicado en 2015

Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma.

artículo científico publicado en 2018

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda